The development of rational strategies for selective immunotherapy against autoimmune demyelinating disease.
Steinman
L
L
Department of Neurology and Neurological Sciences, Stanford University School of Medicine, California 94305.
D000595:Amino Acid Sequence; D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology / Q000628:therapy*; D002417:Cattle; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology / Q000628:therapy*; D000939:Epitopes / Q000276:immunology; D015329:Gene Rearrangement, T-Lymphocyte; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D051379:Mice; D008815:Mice, Inbred Strains / Q000235:genetics / Q000276:immunology; D008969:Molecular Sequence Data; D009103:Multiple Sclerosis / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D004676:Myelin Basic Protein / Q000235:genetics / Q000276:immunology* / Q000633:toxicity; D010446:Peptide Fragments / Q000633:toxicity; D051381:Rats; D011917:Rats, Inbred Lew / Q000235:genetics / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000276:immunology; D014611:Vaccination
D000939:Epitopes; D006684:HLA-DR Antigens; D004676:Myelin Basic Protein; D010446:Peptide Fragments; D011948:Receptors, Antigen, T-Cell